Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.39% | -6.15% | -16.75% | -4.60% | 11.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.39% | -6.15% | -16.75% | -4.60% | 11.40% |
| Cost of Revenue | 12.60% | -1.74% | -14.30% | -6.20% | 3.35% |
| Gross Profit | 2.57% | -8.78% | -18.17% | -3.60% | 17.00% |
| SG&A Expenses | 45.07% | 39.46% | 33.31% | 23.92% | 14.14% |
| Depreciation & Amortization | 0.71% | -4.30% | -9.00% | -6.81% | -4.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.48% | 24.64% | 15.66% | 12.42% | 8.95% |
| Operating Income | -75.11% | -86.09% | -102.20% | -45.83% | -5.38% |
| Income Before Tax | 31.06% | -16.81% | -85.81% | -21.12% | 16.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.06% | -16.81% | -85.81% | -21.12% | 16.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.06% | -16.81% | -85.81% | -21.12% | 16.40% |
| EBIT | -75.11% | -86.09% | -102.20% | -45.83% | -5.38% |
| EBITDA | -98.60% | -120.37% | -156.51% | -64.12% | -6.59% |
| EPS Basic | 38.46% | 5.10% | -32.61% | 19.86% | 45.26% |
| Normalized Basic EPS | -34.38% | -35.00% | -35.71% | 19.54% | 45.76% |
| EPS Diluted | 36.54% | 4.08% | -32.61% | 19.86% | 45.26% |
| Normalized Diluted EPS | -34.38% | -35.00% | -35.71% | 19.54% | 45.76% |
| Average Basic Shares Outstanding | 19.59% | 28.16% | 38.81% | 42.49% | 46.85% |
| Average Diluted Shares Outstanding | 19.59% | 28.16% | 38.81% | 42.49% | 46.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |